Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic Sarcoma

American Journal of Surgical Pathology

Volumn 33, Issue 11, 2009, Pages 1594-1600

  Chung, Lawrance ^a   Lau, Sean K ^a   Jiang, Zhong ^b   Loera, Sofia ^a   Bedel, Victoria ^a   Ji, Jianling ^a   Weiss, Lawrence M ^a   Chu, Peiguo G ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

CDK4; Dedifferentiated liposarcoma; Fluorescence in situ hybridization; Immunohistochemistry; PPAR g. MDM2; Undifferentiated highgrade pleomorphic sarcoma

Indexed keywords

CYCLIN DEPENDENT KINASE 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN MDM2;

ABDOMINAL CANCER; ADULT; AGED; ARTICLE; CANCER MORPHOLOGY; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; ILEUM CANCER; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; LUNG SARCOMA; MALE; NECK CANCER; PELVIS CANCER; RETROPERITONEAL SARCOMA; RETROPERITONEUM; TUMOR DIFFERENTIATION;

ADIPOCYTES; ADOLESCENT; ADULT; AGED; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE 4; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOSARCOMA; LIPOSARCOMA, MYXOID; MALE; MIDDLE AGED; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-MDM2; RETROPERITONEAL NEOPLASMS; SOFT TISSUE NEOPLASMS; THIGH; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 70350461511     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181accb01     Document Type: Article

References (22)

1. Binh MB, Sastre-Garau X, Guillou L, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol. 2005;29:1340-1347.
2. Binh MB, Garau XS, Guillou L, et al. Reproducibility of MDM2 and CDK4 staining in soft tissue tumors. Am J Clin Pathol. 2006; 125:693-697.
3. Binh MB, Guillou L, Hostein I, et al. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas. Am J Surg Pathol. 2007;31:1557-1566.
4. Coindre JM, Mariani O, Chibon F, et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol. 2003;16:256-262.
5. Coindre JM, Hostein I, Maire G, et al. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histologi-cal review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol. 2004;203:822-830
6. dei Tos AP, Wadden C, Fletcher CDM. S-100 protein staining in liposarcoma. Its diagnostic utility in the high grade myxoid (round cell) variant. Appl Immunohistochem Mol Morphol. 1996;4:95-101.
7. Fletcher CD, Unni KK, Mertens F. Tumor of Soft Tissue and Bone. Lyon: IARCPress; 2002:120-126.
8. Henricks WH, Chu YC, Goldblum JR, et al. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol. 1997;21:271-281.
9. Horvai AE, Schaefer JT, Nakakura EK, et al. Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated lipo-sarcoma from other retroperitoneal sarcomas. Mod Pathol. 2008; 21:517-524.
10. Italiano A, Bianchini L, Keslair F, et al. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer. 2008;122:2233-2241.
11. McCormick D, Mentzel T, Beham A, et al. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol. 1994;18:1213-1223.
12. Meis-Kindblom JM, Sjogren H, Kindblom LG, et al. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis. Virchows Arch. 2001;439:141-151.
13. Pilotti S, Della TG, Lavarino C, et al. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22. J Pathol. 1998;185:188-190.
14. Schneider-Stock R, Walter H, Radig K, et al. MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas. J Cancer Res Clin Oncol. 1998;124:532-540.
15. Sirvent N, Forus A, Lescaut W, et al. Characterization of centromere alterations in liposarcomas. Genes Chromosomes Cancer. 2000;29:117-129.
16. Sirvent N, Coindre JM, Maire G, et al. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Am J Surg Pathol. 2007;31:1476-1489.
17. Suster S, Morrison C. Sclerosing poorly differentiated liposarcoma: clinicopathological, immunohistochemical and molecular analysis of a distinct morphological subtype of lipomatous tumour of soft tissue. Histopathology. 2008;52:283-293.
18. Szymanska J, Tarkkanen M, Wiklund T, et al. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer. 1996;15:89-94.
19. Szymanska J, Virolainen M, Tarkkanen M, et al. Overrepresenta-tion of 1q21-23 and 12q13-21 in lipoma-like liposarcomas but not in benign lipomas: a comparative genomic hybridization study. Cancer Genet Cytogenet. 1997;99:14-18.
20. Tontonoz P, Hu E, Graves RA, et al. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994;8: 1224-1234.
21. Trahan S, Erickson-Johnson MR, Rodriguez F, et al. Formation of the 12q14-q15 amplicon precedes the development of a well-differentiated liposarcoma arising from a nonchondroid pulmonary hamartoma. Am J Surg Pathol. 2006;30:1326-1329.
22. Weaver J, Downs-Kelly E, Goldblum JR, et al. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol. 2008;21:943-949